{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:48:58Z","timestamp":1792162138054,"version":"4.4.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Colorectal dysplasia represents an early stage of colorectal carcinogenesis and is closely associated with chronic inflammation and altered microRNA (miRNA) expression. Probiotic strains such as\n                      <jats:italic>Weizmannia coagulans (formerly Bacillus coagulans)<\/jats:italic>\n                      and\n                      <jats:italic>Saccharomyces boulardii<\/jats:italic>\n                      possess anti-inflammatory properties and may influence host miRNA expression, suggesting their potential as prophylactic agents against inflammation-associated colorectal dysplasia.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Mice received prophylactic oral administration of\n                      <jats:italic>Weizmannia coagulans<\/jats:italic>\n                      or\n                      <jats:italic>Saccharomyces boulardii<\/jats:italic>\n                      beginning one week before azoxymethane\/dextran sulfate sodium (AOM\/DSS) induction and continuing throughout the experimental period. Histopathological examination, TNF-\u03b1 immunohistochemistry, serum pro-inflammatory cytokine measurements, and miRNA expression profiling using reverse transcription quantitative polymerase chain reaction (RT-qPCR) were performed to evaluate the prophylactic effects of both probiotic strains.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Prophylactic administration of both probiotic strains significantly attenuated early dysplastic alterations and inflammatory cell infiltration compared with the AOM\/DSS group (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). These histopathological improvements were accompanied by significantly lower serum levels of the pro-inflammatory cytokines IL-6 and IL-1\u03b2, together with reduced TNF-\u03b1 immunoreactivity (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). In addition, probiotic pretreatment attenuated the altered miRNA expression profile induced by AOM\/DSS. Compared with the model group, expression of miR-122-5p, miR-29b-5p, and miR-15b-5p was significantly reduced, whereas miR-98-5p, miR-202-5p, miR-21-5p, and let-7i-5p showed increased expression and were associated with miRNA expression patterns that more closely resembled those of the control group (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Prophylactic administration of\n                      <jats:italic>Weizmannia coagulans<\/jats:italic>\n                      and\n                      <jats:italic>Saccharomyces boulardii<\/jats:italic>\n                      reduced inflammation-associated early dysplastic changes while preserving normal miRNA expression patterns in an AOM\/DSS-induced murine model. These findings support the potential of probiotic prophylaxis as an early preventive strategy against colorectal dysplasia and provide a foundation for future studies investigating its clinical applicability.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12866-026-05634-z","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:43:42Z","timestamp":1791251022000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prophylactic administration of probiotic strains Weizmannia coagulans and Saccharomyces boulardii attenuates early dysplastic changes in an AOM\/DSS-induced mouse model"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6852-3954","authenticated-orcid":false,"given":"Marwa","family":"Matboli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8591-3244","authenticated-orcid":false,"given":"Sanaa","family":"Eissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reham Hussein","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Kotb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6562-2132","authenticated-orcid":false,"given":"Ghada Galal","family":"Hamam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Tarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0705-8240","authenticated-orcid":false,"given":"Nagwa M. Abo El","family":"Magd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0087-0674","authenticated-orcid":false,"given":"Abdullah M.","family":"Abdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisha Mohamed","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naydeen","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5622-0887","authenticated-orcid":false,"given":"Marwa Mostafa","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"key":"5634_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"key":"5634_CR2","unstructured":"Colorectal Cancer Facts &. Figures | Facts About Colon Cancer | Am Cancer Soc. https:\/\/www.cancer.org\/research\/cancer-facts-statistics\/colorectal-cancer-facts-figures.html. Accessed 18 Jan 2026."},{"key":"5634_CR3","doi-asserted-by":"publisher","unstructured":"Yehia SA, Alboraie M, Ashour R, Hassan D, Ezzat R, El-Raey F, et al. Enhancing colorectal cancer prevention: a national assessment of public awareness in Egypt. BMC Public Health. 2024;24. https:\/\/doi.org\/10.1186\/S12889-024-18746-W.","DOI":"10.1186\/S12889-024-18746-W"},{"key":"5634_CR4","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Greten FR, Karin M. Immunity, Inflammation, and Cancer. Cell. 2010;140:883\u201399. https:\/\/doi.org\/10.1016\/j.cell.2010.01.025.","journal-title":"Cell"},{"key":"5634_CR5","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1007\/S10620-023-07972-8","volume":"68","author":"SM Jain","year":"2023","unstructured":"Jain SM, Deka D, Das A, Paul S, Pathak S, Banerjee A. Role of Interleukins in Inflammation-Mediated Tumor Immune Microenvironment Modulation in Colorectal Cancer Pathogenesis. Dig Dis Sci. 2023;68:3220\u201336. https:\/\/doi.org\/10.1007\/S10620-023-07972-8.","journal-title":"Dig Dis Sci"},{"key":"5634_CR6","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1186\/S40001-025-02734-W","volume":"30","author":"S Sadati","year":"2025","unstructured":"Sadati S, Khalaji A, Bonyad A, Khoshdooz S, Kolbadi KSH, Bahrami A, et al. NF-\u03baB and apoptosis: colorectal cancer progression and novel strategies for treatment. Eur J Med Res. 2025;30:616. https:\/\/doi.org\/10.1186\/S40001-025-02734-W.","journal-title":"Eur J Med Res"},{"key":"5634_CR7","doi-asserted-by":"publisher","unstructured":"Xiong B, Huang Q, Zheng H, Lin S, Xu J. Recent advances microRNAs and metabolic reprogramming in colorectal cancer research. Front Oncol. 2023;13. https:\/\/doi.org\/10.3389\/fonc.2023.1165862.","DOI":"10.3389\/fonc.2023.1165862"},{"key":"5634_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3892\/IJMM.2024.5474","volume":"55","author":"W Qiu","year":"2024","unstructured":"Qiu W, Akanyibah FA, Xia Y, Ocansey DKW, Mao F, Liang Y. Emerging role of small RNAs in inflammatory bowel disease and associated colorectal cancer (Review). Int J Mol Med. 2024;55:33. https:\/\/doi.org\/10.3892\/IJMM.2024.5474.","journal-title":"Int J Mol Med"},{"key":"5634_CR9","doi-asserted-by":"publisher","unstructured":"Xing Y, Wang Z, Lu Z, Xia J, Xie Z, Jiao M, et al. MicroRNAs: immune modulators in cancer immunotherapy. Immunotherapy Adv. 2021;1. https:\/\/doi.org\/10.1093\/immadv\/ltab006.","DOI":"10.1093\/immadv\/ltab006"},{"key":"5634_CR10","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.3390\/CANCERS17132135\/S1","volume":"17","author":"G Sychowski","year":"2025","unstructured":"Sychowski G, Romanowicz H, Ciesielski W, Hogendorf P, Durczy\u0144ski A, Smolarz B. Diagnostic and therapeutic potential of selected microRNAs in colorectal cancer: a literature review. Cancers (Basel). 2025;17:2135. https:\/\/doi.org\/10.3390\/CANCERS17132135\/S1.","journal-title":"Cancers (Basel)"},{"key":"5634_CR11","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/S12672-025-01996-4","volume":"16","author":"DS Morsli","year":"2025","unstructured":"Morsli DS, Tbahriti HF, Rahli F, Mahammi FZ, Nagdalian A, Hemeg HA, et al. Probiotics in colorectal cancer prevention and therapy: mechanisms, benefits, and challenges. Discover Oncol. 2025;16:406. https:\/\/doi.org\/10.1007\/S12672-025-01996-4.","journal-title":"Discover Oncol"},{"key":"5634_CR12","doi-asserted-by":"publisher","unstructured":"Thoda C, Touraki M. Molecular Mechanisms of probiotic action against gastrointestinal cancers. Int J Mol Sci. 2025;26. https:\/\/doi.org\/10.3390\/IJMS26167857.","DOI":"10.3390\/IJMS26167857"},{"key":"5634_CR13","doi-asserted-by":"publisher","first-page":"1337185","DOI":"10.3389\/FMICB.2024.1337185\/BIBTEX","volume":"15","author":"Z Liu","year":"2024","unstructured":"Liu Z, Liu T, Zhang Z, Fan Y. Bacillus coagulans regulates gut microbiota and ameliorates the alcoholic-associated liver disease in mice. Front Microbiol. 2024;15:1337185. https:\/\/doi.org\/10.3389\/FMICB.2024.1337185\/BIBTEX.","journal-title":"Front Microbiol"},{"key":"5634_CR14","doi-asserted-by":"publisher","unstructured":"Jin Y, Niu Z, Feng M, Che H, Liang Z. Inactivated cells and metabolites of saccharomyces boulardii alleviate inflammation damage in Caco-2 monolayer cells and mice with ulcerative colitis. Antioxidants. 2025;14. https:\/\/doi.org\/10.3390\/ANTIOX14060737.","DOI":"10.3390\/ANTIOX14060737"},{"key":"5634_CR15","doi-asserted-by":"publisher","unstructured":"Ahmed EA, Rajendran P, Scherthan H. The microRNA-202 as a diagnostic biomarker and a potential tumor suppressor. Int J Mol Sci. 2022;23. https:\/\/doi.org\/10.3390\/ijms23115870.","DOI":"10.3390\/ijms23115870"},{"key":"5634_CR16","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.gene.2018.08.064","volume":"676","author":"SB Ke","year":"2018","unstructured":"Ke SB, Qiu H, Chen JM, Shi W, Chen YS. MicroRNA-202-5p functions as a tumor suppressor in colorectal carcinoma by directly targeting SMARCC1. Gene. 2018;676:329\u201335. https:\/\/doi.org\/10.1016\/j.gene.2018.08.064.","journal-title":"Gene"},{"key":"5634_CR17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41575-019-0230-y","volume":"17","author":"G Jung","year":"2020","unstructured":"Jung G, Hern\u00e1ndez-Ill\u00e1n E, Moreira L, Balaguer F, Goel A. Epigenetics of colorectal cancer: biomarker and therapeutic potential. Nat Reviews Gastroenterol Hepatol. 2020;17:111\u201330. https:\/\/doi.org\/10.1038\/s41575-019-0230-y.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"key":"5634_CR18","doi-asserted-by":"publisher","first-page":"8615","DOI":"10.3390\/IJMS26178615","volume":"26","author":"W Paj\u0105k","year":"2025","unstructured":"Paj\u0105k W, Kleinrok J, Pec J, Michno K, Wojtas J, Badach M, et al. Micro RNA in colorectal cancer\u2014potential diagnostic and prognostic markers\u2014an updated review. Int J Mol Sci. 2025;26:8615. https:\/\/doi.org\/10.3390\/IJMS26178615.","journal-title":"Int J Mol Sci"},{"key":"5634_CR19","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/MCO2.104","volume":"2","author":"T Zhang","year":"2021","unstructured":"Zhang T, Ma C, Zhang Z, Zhang H, Hu H. NF-\u03baB signaling in inflammation and cancer. MedComm (Beijing). 2021;2:618\u201353. https:\/\/doi.org\/10.1002\/MCO2.104.","journal-title":"MedComm (Beijing)"},{"key":"5634_CR20","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.7150\/ijbs.46651","volume":"16","author":"J Li","year":"2020","unstructured":"Li J, Huang L, Zhao H, Yan Y, Lu J. The role of interleukins in colorectal cancer. Int J Biol Sci. 2020;16:2323\u201339. https:\/\/doi.org\/10.7150\/ijbs.46651.","journal-title":"Int J Biol Sci"},{"key":"5634_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers12071791","volume":"12","author":"C R\u00e9b\u00e9","year":"2020","unstructured":"R\u00e9b\u00e9 C, Ghiringhelli F. Interleukin-1\u03b2 and cancer. Cancers. 2020;12:1\u201331. https:\/\/doi.org\/10.3390\/cancers12071791.","journal-title":"Cancers"},{"key":"5634_CR22","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.7150\/ijbs.4614","volume":"8","author":"MJ Waldner","year":"2012","unstructured":"Waldner MJ, Foersch S, Neurath MF. Interleukin-6 - A key regulator of colorectal cancer development. Int J Biol Sci. 2012;8:1248\u201353. https:\/\/doi.org\/10.7150\/ijbs.4614.","journal-title":"Int J Biol Sci"},{"key":"5634_CR23","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/cac2.12295","volume":"42","author":"AA Bhat","year":"2022","unstructured":"Bhat AA, Nisar S, Singh M, Ashraf B, Masoodi T, Prasad CP, et al. Cytokine- and chemokine-induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy. Cancer Commun. 2022;42:689\u2013715. https:\/\/doi.org\/10.1002\/cac2.12295.","journal-title":"Cancer Commun"},{"key":"5634_CR24","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1093\/CARCIN\/BGI205","volume":"27","author":"R Suzuki","year":"2005","unstructured":"Suzuki R, Kohno H, Sugie S, Nakagama H, Tanaka T. Strain differences in the susceptibility to azoxymethane and dextran sodium sulfate-induced colon carcinogenesis in mice. Carcinogenesis. 2005;27:162\u20139. https:\/\/doi.org\/10.1093\/CARCIN\/BGI205.","journal-title":"Carcinogenesis"},{"key":"5634_CR25","doi-asserted-by":"publisher","unstructured":"Neufert C, Becker C, Neurath MF. An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression. 2007. https:\/\/doi.org\/10.1038\/nprot.2007.279","DOI":"10.1038\/nprot.2007.279"},{"key":"5634_CR26","doi-asserted-by":"publisher","unstructured":"Arnesen H, M\u00fcller MHB, Aleksandersen M, \u00d8stby GC, Carlsen H, Paulsen JE, et al. Induction of colorectal carcinogenesis in the C57BL\/6J and A\/J mouse strains with a reduced DSS dose in the AOM\/DSS model. Lab Anim Res. 2021;37. https:\/\/doi.org\/10.1186\/S42826-021-00096-Y.","DOI":"10.1186\/S42826-021-00096-Y"},{"key":"5634_CR27","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/J.JFF.2018.10.031","volume":"52","author":"T Shinde","year":"2019","unstructured":"Shinde T, Vemuri R, Shastri MD, Perera AP, Tristram S, Stanley R, et al. Probiotic Bacillus coagulans MTCC 5856 spores exhibit excellent in-vitro functional efficacy in simulated gastric survival, mucosal adhesion and immunomodulation. J Funct Foods. 2019;52:100\u20138. https:\/\/doi.org\/10.1016\/J.JFF.2018.10.031.","journal-title":"J Funct Foods"},{"key":"5634_CR28","unstructured":"Suvarna SK, Layton C, Bancroft JD. Bancroft\u2019s Theory and Practice of Histological Techniques \u2013\u20098th Edition | Elsevier Shop. 2019;306\u201336."},{"key":"5634_CR29","unstructured":"Suvarna SK, Layton C, Bancroft JD. Bancroft\u2019s theory and practice of histological techniques. Seventh Ed. 2012;1\u2013637."},{"key":"5634_CR30","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/METH.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402\u20138. https:\/\/doi.org\/10.1006\/METH.2001.1262.","journal-title":"Methods"},{"key":"5634_CR31","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.3390\/cancers14071732","volume":"14","author":"MS Hossain","year":"2022","unstructured":"Hossain MS, Karuniawati H, Jairoun AA, Urbi Z, Ooi DJ, John A, et al. Colorectal cancer: a review of carcinogenesis, global epidemiology, current challenges, risk factors, preventive and treatment strategies. Cancers (Basel). 2022;14:1732. https:\/\/doi.org\/10.3390\/cancers14071732.","journal-title":"Cancers (Basel)"},{"key":"5634_CR32","doi-asserted-by":"publisher","unstructured":"Borowczak J, Szczerbowski K, Maniewski M, Kowalewski A, Janiczek-Polewska M, Szylberg A, et al. The Role of inflammatory cytokines in the pathogenesis of colorectal carcinoma\u2014recent. Find Rev Biomedicines. 2022;10. https:\/\/doi.org\/10.3390\/biomedicines10071670.","DOI":"10.3390\/biomedicines10071670"},{"key":"5634_CR33","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/S11888-012-0153-2\/METRICS","volume":"9","author":"H Shmuely","year":"2013","unstructured":"Shmuely H, Domniz N, Cohen D. Probiotics in the prevention of colorectal cancer. Curr Colorectal Cancer Rep. 2013;9:31\u20136. https:\/\/doi.org\/10.1007\/S11888-012-0153-2\/METRICS.","journal-title":"Curr Colorectal Cancer Rep"},{"key":"5634_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/8884583","volume":"2020","author":"S Ding","year":"2020","unstructured":"Ding S, Hu C, Fang J, Liu G. The protective role of probiotics against colorectal cancer. Oxid Med Cell Longev. 2020;2020:1\u201310. https:\/\/doi.org\/10.1155\/2020\/8884583.","journal-title":"Oxid Med Cell Longev"},{"key":"5634_CR35","doi-asserted-by":"publisher","unstructured":"Molska M, Regu\u0142a J. Potential mechanisms of probiotics action in the prevention and treatment of colorectal cancer. Nutrients. 2019;11. https:\/\/doi.org\/10.3390\/nu11102453.","DOI":"10.3390\/nu11102453"},{"key":"5634_CR36","doi-asserted-by":"publisher","unstructured":"Cristofori F, Dargenio VN, Dargenio C, Miniello VL, Barone M, Francavilla R. Anti-Inflammatory and immunomodulatory effects of probiotics in gut inflammation: a door to the body. Front Immunol. 2021;12. https:\/\/doi.org\/10.3389\/FIMMU.2021.578386\/PDF.","DOI":"10.3389\/FIMMU.2021.578386\/PDF"},{"key":"5634_CR37","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1093\/carcin\/bgad058","volume":"44","author":"A Chen","year":"2023","unstructured":"Chen A, Jiang Z, Cai L, Tang D. On the road to colorectal cancer development: crosstalk between the gut microbiota, metabolic reprogramming, and epigenetic modifications. Carcinogenesis. 2023;44:631\u201341. https:\/\/doi.org\/10.1093\/carcin\/bgad058.","journal-title":"Carcinogenesis"},{"key":"5634_CR38","doi-asserted-by":"publisher","first-page":"16","DOI":"10.26599\/FSHW.2022.9250002","volume":"13","author":"S Zhang","year":"2024","unstructured":"Zhang S, Li P, Lee S, Wang Y, Tan C, Shang N. Weizmannia coagulans: an ideal probiotic for gut health. Food Sci Hum Wellness. 2024;13:16\u201326. https:\/\/doi.org\/10.26599\/FSHW.2022.9250002.","journal-title":"Food Sci Hum Wellness"},{"key":"5634_CR39","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1177\/1756283X11428502","volume":"5","author":"T Kelesidis","year":"2012","unstructured":"Kelesidis T, Pothoulakis C. Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders. Th Adv Gastroenterol. 2012;5:111\u201325. https:\/\/doi.org\/10.1177\/1756283X11428502.","journal-title":"Th Adv Gastroenterol"},{"key":"5634_CR40","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.3748\/WJG.V16.I18.2202","volume":"16","author":"LV McFarland","year":"2010","unstructured":"McFarland LV. Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World J Gastroenterol. 2010;16:2202\u201322. https:\/\/doi.org\/10.3748\/WJG.V16.I18.2202.","journal-title":"World J Gastroenterol"},{"key":"5634_CR41","doi-asserted-by":"publisher","unstructured":"Zhong B, Zhao Y, Gao L, Yang G, Gao Y, Li F, et al. Anticancer Effects of Weizmannia coagulans MZY531 Postbiotics in CT26 Colorectal Tumor-Bearing Mice by Regulating Apoptosis and Autophagy. Life (Basel). 2024;14. https:\/\/doi.org\/10.3390\/LIFE14101334.","DOI":"10.3390\/LIFE14101334"},{"key":"5634_CR42","doi-asserted-by":"publisher","first-page":"110318","DOI":"10.1016\/j.foodres.2021.110318","volume":"144","author":"ML Cuellar-N\u00fa\u00f1ez","year":"2021","unstructured":"Cuellar-N\u00fa\u00f1ez ML, Gonzalez de Mejia E, Loarca-Pi\u00f1a G. Moringa oleifera leaves alleviated inflammation through downregulation of IL-2, IL-6, and TNF-\u03b1 in a colitis-associated colorectal cancer model. Food Res Int. 2021;144:110318. https:\/\/doi.org\/10.1016\/j.foodres.2021.110318.","journal-title":"Food Res Int"},{"key":"5634_CR43","doi-asserted-by":"publisher","first-page":"10766","DOI":"10.1158\/0008-5472.CAN-07-1418","volume":"67","author":"C Santiago","year":"2007","unstructured":"Santiago C, Pag\u00e1n B, Isidro AA, Appleyard CB. Prolonged chronic inflammation progresses to dysplasia in a novel rat model of colitis-associated colon cancer. Cancer Res. 2007;67:10766\u201373. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-1418.","journal-title":"Cancer Res"},{"key":"5634_CR44","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.31557\/APJCP.2020.21.5.1369","volume":"21","author":"WM Aboulthana","year":"2020","unstructured":"Aboulthana WM, Ibrahim NES, Osman NM, Seif MM, Hassan AK, Youssef AM, et al. Evaluation of the biological efficiency of silver nanoparticles biosynthesized using Croton tiglium L. Seeds extract against azoxymethane induced colon cancer in rats. Asian Pac J Cancer Prev. 2020;21:1369\u201389. https:\/\/doi.org\/10.31557\/APJCP.2020.21.5.1369.","journal-title":"Asian Pac J Cancer Prev"},{"key":"5634_CR45","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.31557\/APJCP.2021.22.10.3267","volume":"22","author":"WM Aboulthana","year":"2021","unstructured":"Aboulthana WM, Shousha WG, Essawy EAR, Saleh MH, Salama AH. Assessment of the anti-cancer efficiency of silver moringa oleifera leaves nano-extract against colon cancer induced chemically in rats. Asian Pac J Cancer Prev. 2021;22:3267\u201386. https:\/\/doi.org\/10.31557\/APJCP.2021.22.10.3267.","journal-title":"Asian Pac J Cancer Prev"},{"key":"5634_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/4061713","volume":"2022","author":"J Wang","year":"2022","unstructured":"Wang J, Ding K, Wang Y, Yan T, Xu Y, Deng Z, et al. Wumei Pill Ameliorates AOM\/DSS-Induced Colitis-Associated Colon Cancer through Inhibition of Inflammation and Oxidative Stress by Regulating S-Adenosylhomocysteine Hydrolase- (AHCY-) Mediated Hedgehog Signaling in Mice. Oxid Med Cell Longev. 2022;2022:1\u201328. https:\/\/doi.org\/10.1155\/2022\/4061713.","journal-title":"Oxid Med Cell Longev"},{"key":"5634_CR47","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4103\/1477-3163.78279","volume":"10","author":"M Robertis","year":"2011","unstructured":"Robertis M, Fazio V, Massi E, Poeta M, Carotti S, Morini S, et al. The AOM\/DSS murine model for the study of colon carcinogenesis: From pathways to diagnosis and therapy studies. J Carcinog. 2011;10:9. https:\/\/doi.org\/10.4103\/1477-3163.78279.","journal-title":"J Carcinog"},{"key":"5634_CR48","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrc2628","volume":"9","author":"F Balkwill","year":"2009","unstructured":"Balkwill F. Tumour necrosis factor and cancer. Nat Reviews Cancer 2009. 2009;9:5. https:\/\/doi.org\/10.1038\/nrc2628.","journal-title":"Nat Reviews Cancer 2009"},{"key":"5634_CR49","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1091\/mbc.E02-09","volume":"14","author":"RC Bates","year":"2003","unstructured":"Bates RC, Mercurio AM. Tumor necrosis factor-stimulates the epithelial-to-mesenchymal transition of human colonic organoids. Mol Biol Cell. 2003;14:1790\u2013800. https:\/\/doi.org\/10.1091\/mbc.E02-09.","journal-title":"Mol Biol Cell"},{"key":"5634_CR50","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun S-C. NF-\u03baB signaling in inflammation. Signal Transduct Target Ther. 2017;2:17023. https:\/\/doi.org\/10.1038\/sigtrans.2017.23.","journal-title":"Signal Transduct Target Ther"},{"key":"5634_CR51","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.bbagrm.2010.05.004","volume":"1799","author":"SC Gupta","year":"2010","unstructured":"Gupta SC, Sundaram C, Reuter S, Aggarwal BB. Inhibiting NF-\u03baB activation by small molecules as a therapeutic strategy. Biochim et Biophys Acta - Gene Regul Mech. 2010;1799:775\u201387. https:\/\/doi.org\/10.1016\/j.bbagrm.2010.05.004.","journal-title":"Biochim et Biophys Acta - Gene Regul Mech"},{"key":"5634_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/FPHAR.2018.00468","author":"A Rodr\u00edguez-Nogales","year":"2018","unstructured":"Rodr\u00edguez-Nogales A, Algieri F, Garrido-Mesa J, Vezza T, Utrilla MP, Chueca N, et al. The Administration of Escherichia coli Nissle 1917 Ameliorates Development of DSS-Induced Colitis in Mice. Front Pharmacol. 2018. https:\/\/doi.org\/10.3389\/FPHAR.2018.00468. 9 MAY.","journal-title":"Front Pharmacol"},{"key":"5634_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S00384-024-04617-8","volume":"39","author":"J Zhang","year":"2024","unstructured":"Zhang J, Guo J, He R, Li J, Du B, Zhang Y, et al. Analysis of the differential expression of serum miR-21-5p, miR-135-5p, and miR-155-5p by Bifidobacterium triplex viable capsules during the perioperative stage of colorectal cancer. Int J Colorectal Disease 2024. 2024;39:1. https:\/\/doi.org\/10.1007\/S00384-024-04617-8.","journal-title":"Int J Colorectal Disease 2024"},{"key":"5634_CR54","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/intimm\/dxaa078","volume":"33","author":"T Hirano","year":"2021","unstructured":"Hirano T. IL-6 in inflammation, autoimmunity and cancer. Int Immunol. 2021;33:127\u201348. https:\/\/doi.org\/10.1093\/intimm\/dxaa078.","journal-title":"Int Immunol"},{"key":"5634_CR55","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.3389\/fimmu.2020.01387","volume":"11","author":"C Peng","year":"2020","unstructured":"Peng C, Ouyang Y, Lu N, Li N. The NF-\u03baB signaling pathway, the microbiota, and gastrointestinal tumorigenesis: recent advances. Front Immunol. 2020;11:1387. https:\/\/doi.org\/10.3389\/fimmu.2020.01387.","journal-title":"Front Immunol"},{"key":"5634_CR56","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s12866-019-1610-8","volume":"19","author":"C Wang","year":"2019","unstructured":"Wang C, Li W, Wang H, Ma Y, Zhao X, Zhang X, et al. Saccharomyces boulardii alleviates ulcerative colitis carcinogenesis in mice by reducing TNF-\u03b1 and IL-6 levels and functions and by rebalancing intestinal microbiota. BMC Microbiol. 2019;19:246. https:\/\/doi.org\/10.1186\/s12866-019-1610-8.","journal-title":"BMC Microbiol"},{"key":"5634_CR57","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1177\/0148607115584387","volume":"40","author":"MLD Consoli","year":"2016","unstructured":"Consoli MLD, Da Silva RS, Nicoli JR, Bru\u00f1a-Romero O, Da Silva RG, De Vasconcelos Generoso S, et al. Randomized clinical trial: impact of oral administration of saccharomyces boulardii on gene expression of intestinal cytokines in patients undergoing colon resection. JPEN J Parenter Enter Nutr. 2016;40:1114\u201321. https:\/\/doi.org\/10.1177\/0148607115584387.","journal-title":"JPEN J Parenter Enter Nutr"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-026-05634-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-026-05634-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-026-05634-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:20:52Z","timestamp":1792160452000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-026-05634-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5634"],"URL":"https:\/\/doi.org\/10.1186\/s12866-026-05634-z","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]},"assertion":[{"value":"25 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The experimental protocol for this study was reviewed and approved by the Research Ethics Committee of the Faculty of Medicine, Ain Shams University, Cairo, Egypt, in compliance with the ethical standards outlined in the Guide for the Care and Use of Laboratory Animals by the International Council on Harmonization (ICH) and the Islamic Organization of Medical Sciences (IOMS). The study also adhered to the guidelines of the United States Office for Human Research Protections and the United States Code of Federal Regulations, under federal-wide assurance No. 000017585. All procedures involving laboratory animals were conducted in accordance with the ethical standards of the institution and the national research committee. The experimental work complied with the ethical principles established by the 1964 Declaration of Helsinki and its later amendments.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"895"}}